← Every applicant

Inventia FDA Approvals

4 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product
DAPAGLIFLOZINNew drugApr 6, 2026TABLET, ORAL
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)New drugFeb 18, 2022CAPSULE, ORAL
CHLORTHALIDONENew drugFeb 9, 2022TABLET, ORAL
ROSUVASTATIN CALCIUMNew drugFeb 5, 2021TABLET, ORAL

Related datasets